[
    {
        "releaseTime": "Feb-18-23 09:07AM",
        "title": "2 Marvelous Growth Stocks to Buy Today and Hold for 5 Years or Longer",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/688195f8-db2a-376e-8327-07c8de9ee097/2-marvelous-growth-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-17-23 02:00PM",
        "title": "Beat the Dow Jones With CRISPR Therapeutics Stock",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0c9a5160-a7c6-3420-a645-fdb229cc22a4/beat-the-dow-jones-with.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-17-23 10:23AM",
        "title": "These 2 Biotech Stocks Could Soar in the Next Bull Market",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/01796173-3a5c-3a22-b42d-6614b4551b9c/these-2-biotech-stocks-could.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-14-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-dips-230011637.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-14-23 03:52PM",
        "title": "Ark Invest Stock Portfolio: 15 Biggest Positions",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/ark-invest-stock-portfolio-15-205238465.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-14-23 07:10AM",
        "title": "3 Prime Healthcare Takeover Targets",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0b3bba48-2dd1-31ac-813b-d9e95b4424dc/3-prime-healthcare-takeover.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-12-23 05:30AM",
        "title": "These Cheap Growth Stocks Could Supercharge Your Portfolio",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/267bf5bd-2203-3686-a96c-a6133b83d886/these-cheap-growth-stocks.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-10-23 08:30AM",
        "title": "Could CRISPR Therapeutics Stock Help You Become a Millionaire?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/2a1727d0-7337-384d-8143-9e54407ba66d/could-crispr-therapeutics.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-09-23 09:48AM",
        "title": "CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-crsp-report-q4-earnings-144802211.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-09-23 08:00AM",
        "title": "2 Biotech Stocks That Could Make You Richer",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/5a772b9a-6e52-3a21-86d0-42adc0a2dc5f/2-biotech-stocks-that-could.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-09-23 05:56AM",
        "title": "Better Bull Market Buy: CRISPR Therapeutics or Vertex Pharmaceuticals?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/785cc5c9-25c0-30d8-8fe5-3bcb987ba0c9/better-bull-market-buy%3A.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-09-23 05:30AM",
        "title": "Wall Street Expects This Stock to Jump 70% This Year. Here's Why It Could Happen.",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0bbc5023-d505-31aa-859b-3fff9a83b1ba/wall-street-expects-this.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-08-23 08:00AM",
        "title": "CRISPR Therapeutics to Participate in Upcoming Investor Conferences",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-participate-upcoming-investor-130000599.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-06-23 08:15AM",
        "title": "Ready to Buy the Dip? Consider This Gene Editing Stock",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/284c7348-5b36-3875-adcd-97536a8744f1/ready-to-buy-the-dip%3F.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-06-23 05:55AM",
        "title": "3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129%",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/e43ea65a-8574-37c2-b7e7-70818b51da2a/3-cathie-wood-stocks-wall.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-03-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-dips-230011722.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-03-23 02:00PM",
        "title": "3 No-Brainer Growth Stocks to Buy in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/8fecd690-7e74-31b6-8753-0b40f892fafd/3-no-brainer-growth-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-03-23 12:10PM",
        "title": "Why Editas Medicine's Shares Jumped This Week",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/9aba8718-6083-3e60-bdf8-aab36d6bb761/why-editas-medicine%27s-shares.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-03-23 03:52AM",
        "title": "Strength Seen in CRISPR Therapeutics AG (CRSP): Can Its 7.2% Jump Turn into More Strength?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/strength-seen-crispr-therapeutics-ag-085208932.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-02-23 12:58PM",
        "title": "3 CRISPR Stocks to Buy Now Or Youll Be Kicking Yourself Later",
        "publisher": " InvestorPlace +7.24%",
        "webUrl": "https://finance.yahoo.com/news/3-crispr-stocks-buy-now-175823968.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-31-23 10:00AM",
        "title": "3 Things About CRISPR Therapeutics That Smart Investors Know",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/443b8bdc-67de-3024-8ef1-65dc556ed246/3-things-about-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-30-23 07:10PM",
        "title": "7 CRISPR Stocks With the Best Long-Term Potential",
        "publisher": " InvestorPlace -5.34%",
        "webUrl": "https://finance.yahoo.com/news/7-crispr-stocks-best-long-001035830.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-26-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-stock-230011007.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-25-23 07:27AM",
        "title": "3 Gene Editing Stocks With the Best Long-Term Potential",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/3-gene-editing-stocks-best-122758609.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-24-23 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-gains-231511948.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-22-23 09:00AM",
        "title": "Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/a34ce541-c40c-364c-aa7f-b04b53d2c805/better-biotech-buy%3A-bluebird.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-20-23 10:23AM",
        "title": "The Best Stocks to Invest $5,000 In Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/042c5d42-ac5e-3b48-9345-8c2e0c7c82db/the-best-stocks-to-invest.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-20-23 05:30AM",
        "title": "A Look At The Fair Value Of CRISPR Therapeutics AG (NASDAQ:CRSP)",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/look-fair-value-crispr-therapeutics-103030815.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-19-23 10:07AM",
        "title": "CRISPR Therapeutics Stock: Bull vs. Bear",
        "publisher": " Motley Fool -5.70%",
        "webUrl": "https://finance.yahoo.com/m/5382b339-56f7-329b-92d2-4acdcae4814a/crispr-therapeutics-stock%3A.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-18-23 03:44PM",
        "title": "7 Biotech Stocks That Will Make You Rich in 10 Years",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-biotech-stocks-rich-10-204449431.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-18-23 03:40PM",
        "title": "3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/3-crispr-stocks-filthy-rich-204013714.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-16-23 05:30AM",
        "title": "2 Stocks Down More Than 25% to Buy Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/a5ea86c3-8539-3bca-855e-1f17f56b52e0/2-stocks-down-more-than-25%25.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-13-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-outpaces-230011132.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-13-23 05:30AM",
        "title": "5 Potentially Explosive Stocks to Buy in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/1d4dbf00-6fac-3670-b4d9-bf92f4211f1f/5-potentially-explosive.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-12-23 06:23AM",
        "title": "More Likely to 5X First: CRISPR Therapeutics vs. InMode",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/61f4d096-d049-3e4c-8955-16ff19bb50ad/more-likely-to-5x-first%3A.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-11-23 09:37AM",
        "title": "2 Growth Stocks You May Regret not Buying Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/d5cb8ba0-db50-3155-84ce-c672d9de01bb/2-growth-stocks-you-may.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-11-23 08:00AM",
        "title": "CRISPR Therapeutics to Participate in B. Riley Securities 3rd Annual Oncology Conference",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-participate-b-riley-130000239.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-09-23 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-dips-231511556.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-07-23 08:15AM",
        "title": "2 Risky Cathie Wood Stocks to Buy Today And Hold For 5 Years",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/08285699-21d5-3f96-8395-858602d66aa2/2-risky-cathie-wood-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-06-23 08:45AM",
        "title": "2 Under-the-Radar Biotech Stocks to Buy in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/39fe40a3-7db0-32ce-8c3f-e597eb342bb5/2-under-the-radar-biotech.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Jan-04-23 06:00AM",
        "title": "Cathie Wood Is Buying These Top Growth Stocks -- and Both Could Make You Rich Over Time",
        "publisher": " Motley Fool +9.76%",
        "webUrl": "https://finance.yahoo.com/m/c799586f-7d71-3fe4-889b-db234545fd39/cathie-wood-is-buying-these.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-31-22 05:52AM",
        "title": "3 Growth Stocks That Could Skyrocket 50% or More In 2023, According to Wall Street",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/6138e785-a2e5-36e6-bad0-3a5e6e14ae64/3-growth-stocks-that-could.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-30-22 10:07AM",
        "title": "1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/10a52083-068b-386a-ace7-00dbd8107e46/1-cathie-wood-stock-to-buy.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-29-22 05:59PM",
        "title": "15 Most Advanced Countries in Europe",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/15-most-advanced-countries-europe-225911408.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-27-22 10:20AM",
        "title": "Could CRISPR Therapeutics Help You Become a Millionaire?",
        "publisher": " Motley Fool -6.99%",
        "webUrl": "https://finance.yahoo.com/m/60e4cf34-f8b2-396d-83bb-f9066e9bd646/could-crispr-therapeutics.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-22-22 10:25AM",
        "title": "Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023?",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/d5b49c62-b3d9-3cf5-986c-9fa718277737/crispr-stock-in-2023%3A-will.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-22-22 06:19AM",
        "title": "3 Cathie Wood Stocks That Could Make Big Comebacks in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/faf495d6-126d-3c8d-bb69-5bae1d609e15/3-cathie-wood-stocks-that.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-19-22 08:30AM",
        "title": "CRISPR Therapeutics Announces the Appointment of Alex Harding, M.D., M.B.A., as Head of Business Development",
        "publisher": " GlobeNewswire -5.06%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-announces-appointment-alex-133000847.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-17-22 09:15AM",
        "title": "3 Beaten-Down Stocks That Could Explode Higher in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/1d50c2c1-f69a-3eab-8e56-05e5189242ef/3-beaten-down-stocks-that.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-16-22 03:07PM",
        "title": "14 Best ARK Stocks To Buy Now",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/14-best-ark-stocks-buy-200711874.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-16-22 12:09PM",
        "title": "7 Stocks to Add to Your 10x Watchlist",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-stocks-add-10x-watchlist-170903848.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-12-22 10:00AM",
        "title": "CRISPR Therapeutics Provides Update on Its Ongoing Phase 1 CARBON Trial of CTX110®",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-provides-ongoing-phase-150000313.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-10-22 08:00AM",
        "title": "Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/vertex-crispr-therapeutics-present-american-130000205.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-09-22 09:51AM",
        "title": "Despite shrinking by US$301m in the past week, CRISPR Therapeutics (NASDAQ:CRSP) shareholders are still up 165% over 5 years",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/despite-shrinking-us-301m-past-145134154.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-09-22 09:45AM",
        "title": "Want to Be Ready For a New Bull Market? Do These 3 Things Soon",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/3defac6e-33d8-3d14-9b25-ae3672fd74da/want-to-be-ready-for-a-new.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-08-22 10:15AM",
        "title": "3 Revolutionary Stocks I'd Buy Right Now Without Hesitation",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/44269e5b-04c8-3f5d-bfaf-2a5933d231e4/3-revolutionary-stocks-i%27d.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-08-22 09:20AM",
        "title": "Is CRISPR Therapeutics a Buy?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/019fe92e-c513-3947-823f-0e416f586ad1/is-crispr-therapeutics-a-buy%3F.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-06-22 06:30AM",
        "title": "Bear Market Bargain Hunting: 3 Top Stocks to Buy Before 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/12/06/bear-market-bargains-3-stocks-to-buy-before-2023/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-05-22 03:49PM",
        "title": "13 Best Genomics Stocks To Buy Now",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/13-best-genomics-stocks-buy-204956748.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-01-22 11:31AM",
        "title": "Why Is CRISPR Therapeutics AG (CRSP) Up 0.2% Since Last Earnings Report?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/why-crispr-therapeutics-ag-crsp-163104925.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Dec-01-22 08:00AM",
        "title": "CRISPR Therapeutics to Present at the 2022 BMO Growth & ESG Conference",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-present-2022-bmo-130000414.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-17-22 10:07AM",
        "title": "2 Growth Stocks That Could Double in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/11/17/2-stocks-that-could-double-in-2023/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-15-22 06:30AM",
        "title": "Crispr Therapeutics Stock: Bull vs. Bear",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/11/15/crispr-therapeutics-stock-bull-vs-bear/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-14-22 02:31PM",
        "title": "10 Most Promising Gene Therapy Companies to Watch",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/10-most-promising-gene-therapy-193131538.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-12-22 08:14AM",
        "title": "We Think CRISPR Therapeutics (NASDAQ:CRSP) Can Afford To Drive Business Growth",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/think-crispr-therapeutics-nasdaq-crsp-131447394.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-10-22 05:40PM",
        "title": "CRISPR Therapeutics Presents Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting",
        "publisher": " GlobeNewswire +11.77%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-presents-data-society-224000176.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-09-22 05:30AM",
        "title": "3 Healthcare Stocks That Could Go Parabolic",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/11/09/3-healthcare-stocks-that-could-go-parabolic/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-07-22 11:22AM",
        "title": "Why Shares of CRISPR Therapeutics Dropped 19.9% in October",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/11/07/why-shares-of-crispr-therapeutics-dropped-199-in-o/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-04-22 06:00AM",
        "title": "3 Top Healthcare Stocks to Buy for November",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/11/04/3-top-healthcare-stocks-to-buy-for-november/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-03-22 09:06AM",
        "title": "CRISPR Therapeutics Announces Poster Presentation on CTX110® at the American Society of Hematology (ASH) 2022 Annual Meeting",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-announces-poster-presentation-130600147.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-02-22 12:51PM",
        "title": "CRISPR Therapeutics (CRSP) Q3 Earnings Top, Sales Lag Estimates",
        "publisher": " Zacks +5.11%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-crsp-q3-earnings-165104861.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-01-22 05:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-reports-211509887.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Nov-01-22 04:01PM",
        "title": "CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200100899.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-31-22 07:20PM",
        "title": "7 Undervalued Biotech Stocks to Buy Before They Boom",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-undervalued-biotech-stocks-buy-144322825.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-28-22 06:36PM",
        "title": "Why Shares of Vertex Pharmaceuticals Jumped 9.03% on Friday",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/10/28/why-shares-of-vertex-pharmaceuticals-jumped-903-on/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-28-22 12:07PM",
        "title": "Vertex (VRTX) Beats on Q3 Earnings, Ups 2022 Sales Guidance",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/vertex-vrtx-beats-q3-earnings-160704667.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-27-22 10:02AM",
        "title": "Earnings Preview: Exact Sciences (EXAS) Q3 Earnings Expected to Decline",
        "publisher": " Zacks -5.14%",
        "webUrl": "https://finance.yahoo.com/news/earnings-preview-exact-sciences-exas-140202724.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-27-22 09:30AM",
        "title": "Better Buy: CRISPR Therapeutics vs. Bluebird Bio",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/10/27/better-buy-crispr-therapeutics-vs-bluebird-bio/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-27-22 08:30AM",
        "title": "CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-announces-planned-transition-123000686.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-26-22 10:02AM",
        "title": "CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?",
        "publisher": " Zacks +5.24%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-expected-140202302.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-25-22 01:34PM",
        "title": "Vertex (VRTX) to Report Q3 Earnings: What's in the Cards?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/vertex-vrtx-report-q3-earnings-173405735.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-25-22 12:53PM",
        "title": "CRISPR (CRSP) to Report Q3 Earnings: What's in the Cards?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-crsp-report-q3-earnings-165304013.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-21-22 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-stock-221510995.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-21-22 11:08AM",
        "title": "CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://www.investors.com/news/technology/crispr-stocks-biggest-names-gene-editing-grappling-with-risks-behind-their-cures/?src=A00220",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-19-22 09:53AM",
        "title": "2 Under-the-Radar Biotech Stocks to Buy in 2022",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/10/19/2-under-the-radar-biotech-stocks-to-buy-in-2022/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-19-22 09:24AM",
        "title": "ARK Invest Stock Portfolio: Top 10 Picks",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/ark-invest-stock-portfolio-top-132442835.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-16-22 08:29AM",
        "title": "In the wake of CRISPR Therapeutics AG's (NASDAQ:CRSP) latest US$591m market cap drop, institutional owners may be forced to take severe actions",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/wake-crispr-therapeutics-ags-nasdaq-122903534.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-14-22 09:49AM",
        "title": "10 Best Gene Editing Stocks To Buy",
        "publisher": " Insider Monkey -6.87%",
        "webUrl": "https://finance.yahoo.com/news/10-best-gene-editing-stocks-134941899.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-13-22 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-stock-221510491.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-06-22 08:45AM",
        "title": "The Zacks Analyst Blog Highlights CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-crispr-124512881.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-05-22 09:51AM",
        "title": "Why Vertex Pharmaceuticals' Shares Rose 2.8% in September",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/10/05/why-vertex-pharmaceuticals-shares-rose-28-in-septe/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-05-22 08:15AM",
        "title": "Where to Invest $500 Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/10/05/where-to-invest-500-right-now/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-05-22 08:05AM",
        "title": "CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-present-society-immunotherapy-120500522.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-04-22 06:40AM",
        "title": "1 Growth Stock That'll Beat Amazon and 1 That Probably Won't (for Now)",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/10/04/1-growth-stock-thatll-beat-amazon-and-1-that-proba/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Oct-02-22 10:00AM",
        "title": "2 Top Biotech Stocks to Buy for the Long Haul",
        "publisher": " Motley Fool",
        "webUrl": "https://www.fool.com/investing/2022/10/02/2-top-biotech-stocks-to-buy-for-the-long-haul/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article",
        "company": "CRSP"
    },
    {
        "releaseTime": "Sep-30-22 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-gains-221510286.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Sep-29-22 08:00AM",
        "title": "CRISPR Therapeutics to Present at the BMO Biopharma Spotlight Series: Gene Editing and Therapy",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-present-bmo-biopharma-120000233.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Sep-28-22 01:17PM",
        "title": "Vertex (VRTX), CRISPR to Seek FDA Nod for Hemoglobinopathy Therapy",
        "publisher": " Zacks +5.20%",
        "webUrl": "https://finance.yahoo.com/news/vertex-vrtx-crispr-seek-fda-171705210.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Sep-28-22 12:39PM",
        "title": "MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders",
        "publisher": " Benzinga",
        "webUrl": "https://finance.yahoo.com/news/maxcyte-inks-platform-license-vertex-163911297.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Sep-28-22 11:44AM",
        "title": "Stock Market Gains Strengthen As Yield Backs Away From 4%; This Biotech Soars 35%",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://www.investors.com/market-trend/stock-market-today/stock-market-higher-as-yield-hits-4-apple-falters-this-biotech-soars-40/?src=A00220",
        "company": "CRSP"
    }
]